Rachel Sanford

Impact of Time from Completion of Neoadjuvant Chemotherapy to Surgery on Survival Outcomes in Breast Cancer Patients

Rachel Sanford, Xiudong Lei, Carlos H. Bárcenas et al. · Annals of Surgical Oncology · 2015 · 119 citations

Surgical Oncology, Survival Outcomes, Breast Oncology +8

High incidence of germline <i>BRCA</i> mutation in patients with ER low‐positive/PR low‐positive/HER‐2 <i>neu</i> negative tumors

Rachel Sanford, Juhee Song, Angelica M. Gutierrez‐Barrera et al. · Cancer · 2015 · 98 citations · Full text

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

Sasha E. Stanton, Maureen M. Ward, Paul J. Christos et al. · BMC Cancer · 2015 · 68 citations · Full text

Consolidative Use of Radiotherapy to Block (CURB) Oligoprogression ― Interim Analysis of the First Randomized Study of Stereotactic Body Radiotherapy in Patients With Oligoprogressive Metastatic Cancers of the Lung and Breast

C. Jillian Tsai, Jie Yang, David Guttmann et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 67 citations

Radiation Medicine, Cancer Therapeutics, Radiation Therapy +13

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Karen A. Autio, Christopher A. Klebanoff, David Schaer et al. · Clinical Cancer Research · 2020 · 59 citations · Full text